Neutral sphingomyelinase in physiological and measles virus induced T cell suppression

Nora Mueller1, Elita Avota1, Lena Collenburg1

  • 1University of Würzburg, Institute for Virology and Immunobiology, Wuerzburg, Germany.

Plos Pathogens
|December 19, 2014
PubMed

Insights

Neutral sphingomyelinase 2 (NSM2) dampens T cell responses during normal stimulation. Measles virus exploits NSM2, causing pathological T cell suppression and immune dysfunction.

Area of Science:

  • Immunology
  • Cell Biology
  • Virology

Background:

  • T cell paralysis is a hallmark of measles virus (MV) induced immunosuppression.
  • MV interferes with T cell actin reorganization via sphingomyelinase activation.
  • The role of sphingomyelinases in T cell activation and immune synapse (IS) regulation is unclear.

Purpose of the Study:

  • To investigate the role of neutral sphingomyelinase 2 (NSM2) in physiological T cell activation.
  • To elucidate the mechanism of MV-induced T cell suppression involving NSM2.
  • To define the function of NSM2 in immune synapse formation and T cell responsiveness.

Main Methods:

  • Studied primary T cells during physiological co-stimulation and MV exposure.
  • Utilized genetic ablation of NSM2 to assess its function.
  • Analyzed actin dynamics, tyrosine phosphorylation, Ca2+-mobilization, ceramide accumulation, and cell expansion.
  • Investigated NSM2 and ceramide localization within the immune synapse.

Main Results:

  • Transient NSM2 activation and localized ceramide accumulation occur during normal T cell co-stimulation.
  • Genetic ablation of NSM2 leads to T cell hyper-responsiveness.
  • MV exposure causes exaggerated NSM2 activation and aberrant ceramide compartmentalization.
  • MV-induced NSM2 overactivation impairs T cell spreading, protein phosphorylation, and expansion.

Conclusions:

  • NSM2 plays a physiological role in dampening T cell responses.
  • Measles virus hijacks NSM2 activation to induce pathological T cell suppression.
  • Understanding NSM2 regulation is crucial for addressing MV-induced immune dysfunction.

Related Concept Videos